BOSTON OMAHA CORP's ticker is BOMN and the CUSIP is 101044105. A total of 100 filers reported holding BOSTON OMAHA CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,636 | -72.2% | 710 | -68.1% | 0.00% | -66.7% |
Q2 2023 | $41,874 | -20.5% | 2,225 | 0.0% | 0.00% | -25.0% |
Q1 2023 | $52,665 | -10.7% | 2,225 | 0.0% | 0.00% | 0.0% |
Q4 2022 | $58,962 | +15.6% | 2,225 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $51,000 | +13.3% | 2,225 | 0.0% | 0.00% | -20.0% |
Q2 2022 | $45,000 | -19.6% | 2,225 | 0.0% | 0.01% | 0.0% |
Q1 2022 | $56,000 | -3.4% | 2,225 | +9.1% | 0.01% | 0.0% |
Q4 2021 | $58,000 | -19.4% | 2,040 | +9.4% | 0.01% | -16.7% |
Q3 2021 | $72,000 | +22.0% | 1,865 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $59,000 | +11.3% | 1,865 | +3.6% | 0.01% | 0.0% |
Q1 2021 | $53,000 | +8.2% | 1,800 | 0.0% | 0.01% | 0.0% |
Q4 2020 | $49,000 | +390.0% | 1,800 | +172.7% | 0.01% | +500.0% |
Q3 2020 | $10,000 | +233.3% | 660 | +230.0% | 0.00% | – |
Q2 2020 | $3,000 | 0.0% | 200 | 0.0% | 0.00% | -100.0% |
Q1 2020 | $3,000 | -25.0% | 200 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $4,000 | +33.3% | 200 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $3,000 | -40.0% | 200 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $5,000 | +25.0% | 200 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $4,000 | 0.0% | 200 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $4,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MAGNOLIA GROUP, LLC | 6,852,860 | $144,390,000 | 30.24% |
Red Cedar Capital, LLC | 424,623 | $8,947,000 | 8.09% |
SANTA MONICA PARTNERS LP | 267,055 | $5,627,000 | 5.28% |
Cowen Prime Services LLC | 103,569 | $2,182,000 | 1.08% |
Ironvine Capital Partners, LLC | 130,162 | $2,743,000 | 0.61% |
Biondo Investment Advisors, LLC | 54,825 | $1,155,000 | 0.29% |
GEORGE KAISER FAMILY FOUNDATION | 28,530 | $601,000 | 0.20% |
FENIMORE ASSET MANAGEMENT INC | 175,040 | $3,688,000 | 0.14% |
Akre Capital Management | 350,000 | $7,374,000 | 0.09% |
ArrowMark Colorado Holdings LLC | 428,750 | $9,034,000 | 0.08% |